US$ 20.29
moa of glp-1 agonists Mechanism action of [25] The dual glucose-dependent insulinotropic polypeptide
Description
By Sabina Paglialunga, PhD & Aernout van Haarst, PhD Senior Directors Scientific Affairs Glucagon-Like Peptide-1 (GLP-1) receptor agonists first came to the market in 2005 as a type 2 diabetes mellitus treatment, and they have been making headlines again for their weight reduction effects
![moa of glp-1 agonists Mechanism action of [25] The dual glucose-dependent insulinotropic polypeptide](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-021-01412-5/MediaObjects/12933_2021_1412_Fig1_HTML.png)
Start your weight-loss journey for the last time.
![moa of glp-1 agonists Mechanism action of [25] The dual glucose-dependent insulinotropic polypeptide](https://www.researchgate.net/publication/256289222/figure/fig1/AS:614177232142337@1523442671231/Mechanism-of-action-of-GLP-1-25.png)
Should I start tirzepatide or semaglutide to treat my MS?
![moa of glp-1 agonists Mechanism action of [25] The dual glucose-dependent insulinotropic polypeptide](https://cdn2.caymanchem.com/cdn/cms/caymanchem/PublishingImages/Lists/NewsItems/AllItems/Summary%20of%20insulin%20and%20glucagon%20pathways%20in%20glucose%20homeostasis.png)
GLP-1 RAs mimic naturally occurring GLP-1, an enterohormone produced in response to oral intake that regulates glucose metabolism and promotes weight loss
![moa of glp-1 agonists Mechanism action of [25] The dual glucose-dependent insulinotropic polypeptide](https://www.mdpi.com/cells/cells-13-00065/article_deploy/html/images/cells-13-00065-g001-550.jpg)
Explore BPS Biosciences solutions for GLP-1R research in diabetes
![moa of glp-1 agonists Mechanism action of [25] The dual glucose-dependent insulinotropic polypeptide](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-024-01931-z/MediaObjects/41392_2024_1931_Fig6_HTML.png)